Diagnostic value of serum VEGF in women with ovarian tumors

Anticancer Research

Volumn 19, Issue 4 A, 1999, Pages 2519-2522

  Oehler, Martin K ^a,b,c   Caffier, H ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Benign ovarian neoplasms; Cystadenoma; ELISA; Ovarian cancer; Serum level; Tumor marker; Vascular endothelial growth factor; VEGF

Indexed keywords

TUMOR MARKER; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; CONFERENCE PAPER; CONTROLLED STUDY; CYSTADENOMA; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; TUMOR VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA; CYSTADENOMA; ENDOMETRIAL NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LYMPHOKINES; MIDDLE AGED; OVARIAN NEOPLASMS; REAGENT KITS, DIAGNOSTIC; REFERENCE VALUES; ROC CURVE; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032805001     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. Folkman J: What is the evidence that tumors are angiogenesis dependent ? J Natl Cancer Inst 82: 4-6, 1990.
2. Weidner N, Semple JP, Welch WR, Folkman J: Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma. N Engl J Med 324: 1-8, 1991.
3. Senger DR, Galli SJ, Dvorak AM, Perruzyi CA, Harvey VS, Dvorak HF: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219: 983-985, 1983.
4. Leung DW, Cachianes G, Kuang W-J, Goeddel DV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309, 1989.
5. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ: Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84: 1470-1478, 1989.
6. Kondo S, Asano M, Matsuo K, Ohmori I, Suzuki H: Vascular endothelial growth factor/vascular permeability factor is detectable in sera of tumor-bearing mice and cancer patients. Biochim Biophys Acta 1221: 211-214, 1994.
7. Yamamoto Y, Toi M, Kondo S, Matsumoto T, Suzuki H, Kitamura M, Tsuruta K, Taniguchi T, Okamoto A, Mori T, Yoshida M, Ikeda T, Tominaga T: Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients. Clin Cancer Res 2: 821-826, 1996.
8. Olson TA, Mohanraj D, Carson LF, Ramakrishnan S: Vascular permeability factor gene expression in normal and neoplastic human ovaries. Cancer Res 54: 276-280, 1994.
9. Yeo KT, Wang HH, Nagy JA, Sioussat TM, Ledbetter SR, Hoogewerf AJ, Zou Y, Masse EM, Senger DR, Dvorak HF, Yeo TK: Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions. Cancer Res 53: 2912-2918, 1993.
10. Dirix LY, Vermeulen PB, Pawinski, A, Prove A, Benoy I, De Pooter C, Martin M, Van Oosterom AT: Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients. Brit J Cancer 76: 238-243, 1997.
11. Kurjak A, Zalud 1, Alfirevic Z: Evaluation of adnexal masses with transvaginal color ultrasound. J Ultrasound Med 10: 295-297, 1991.
12. Yamamoto Y, Toi M, Kondo S, Matsumoto T, Suzuki H, Kitamura M, Tsuruta K, Taniguchi T, Okamoto A, Mori T, Yoshida M, Ikeda T, Tominaga T: Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients. Clin Cancer Res 2: 821-826, 1996.
13. Dirix LY, Vermeulen PB, Pawinski A, Prove A, Benoy 1, De Pooter C, Martin M, Van Oosterom AT: Elevated levels of the angiog,enic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients. Brit J Cancer 76: 238-243, 1997.
14. Abu-Jawdeh GM, Faix JD, Niloff J, Tognazi K, Manseau E, Dvorak HF, Brown LF: Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms. Lab Invest 74: 1105-1115, 1996.
15. Dirix LY, Vermeulen PB, Hubens G, Benoy 1, Martin M, DePooter C, Van Oosterom AT: Serum fibroblast growth factor and vascular endothelial growth factor and tumour kinetics in advanced ovarian cancer. Ann Oncol 7: 843-848, 1996.